205 related articles for article (PubMed ID: 23347159)
21. beta-Arrestin 1 and 2 stabilize the angiotensin II type I receptor in distinct high-affinity conformations.
Sanni SJ; Hansen JT; Bonde MM; Speerschneider T; Christensen GL; Munk S; Gammeltoft S; Hansen JL
Br J Pharmacol; 2010 Sep; 161(1):150-61. PubMed ID: 20718747
[TBL] [Abstract][Full Text] [Related]
22. Covalent Inhibition of the Histamine H
Wágner G; Mocking TAM; Kooistra AJ; Slynko I; Ábrányi-Balogh P; Keserű GM; Wijtmans M; Vischer HF; de Esch IJP; Leurs R
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835873
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into the agonists binding and receptor selectivity of human histamine H
Im D; Kishikawa JI; Shiimura Y; Hisano H; Ito A; Fujita-Fujiharu Y; Sugita Y; Noda T; Kato T; Asada H; Iwata S
Nat Commun; 2023 Oct; 14(1):6538. PubMed ID: 37863901
[TBL] [Abstract][Full Text] [Related]
24. Activation mechanism of the human histamine H4 receptor--an explicit membrane molecular dynamics simulation study.
Jójárt B; Kiss R; Viskolcz B; Keseru GM
J Chem Inf Model; 2008 Jun; 48(6):1199-210. PubMed ID: 18572901
[TBL] [Abstract][Full Text] [Related]
25. Specific Engineered G Protein Coupling to Histamine Receptors Revealed from Cellular Assay Experiments and Accelerated Molecular Dynamics Simulations.
Höring C; Conrad M; Söldner CA; Wang J; Sticht H; Strasser A; Miao Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576210
[TBL] [Abstract][Full Text] [Related]
26. BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H
Verweij EWE; Bosma R; Gao M; van den Bor J; Al Araaj B; de Munnik SM; Ma X; Leurs R; Vischer HF
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328605
[TBL] [Abstract][Full Text] [Related]
27. Label-free versus conventional cellular assays: Functional investigations on the human histamine H
Lieb S; Littmann T; Plank N; Felixberger J; Tanaka M; Schäfer T; Krief S; Elz S; Friedland K; Bernhardt G; Wegener J; Ozawa T; Buschauer A
Pharmacol Res; 2016 Dec; 114():13-26. PubMed ID: 27751876
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
Geyer R; Kaske M; Baumeister P; Buschauer A
Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
[TBL] [Abstract][Full Text] [Related]
29. Phenylalanine 169 in the second extracellular loop of the human histamine H4 receptor is responsible for the difference in agonist binding between human and mouse H4 receptors.
Lim HD; Jongejan A; Bakker RA; Haaksma E; de Esch IJ; Leurs R
J Pharmacol Exp Ther; 2008 Oct; 327(1):88-96. PubMed ID: 18635748
[TBL] [Abstract][Full Text] [Related]
30. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode.
Engelhardt H; Schultes S; de Graaf C; Nijmeijer S; Vischer HF; Zuiderveld OP; Dobler J; Stachurski K; Mayer M; Arnhof H; Scharn D; Haaksma EE; de Esch IJ; Leurs R
J Med Chem; 2013 Jun; 56(11):4264-76. PubMed ID: 23668417
[TBL] [Abstract][Full Text] [Related]
31. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
[TBL] [Abstract][Full Text] [Related]
32. Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs.
Strasser A; Wittmann HJ; Buschauer A; Schneider EH; Seifert R
Trends Pharmacol Sci; 2013 Jan; 34(1):13-32. PubMed ID: 23228711
[TBL] [Abstract][Full Text] [Related]
33. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
[TBL] [Abstract][Full Text] [Related]
34. Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylation.
Sanna MD; Stark H; Lucarini L; Ghelardini C; Masini E; Galeotti N
Pain; 2015 Dec; 156(12):2492-2504. PubMed ID: 26270581
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
[TBL] [Abstract][Full Text] [Related]
36. Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor.
Shin N; Coates E; Murgolo NJ; Morse KL; Bayne M; Strader CD; Monsma FJ
Mol Pharmacol; 2002 Jul; 62(1):38-47. PubMed ID: 12065753
[TBL] [Abstract][Full Text] [Related]
37. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of novel ligands for the histamine H₄ receptor based on a pyrrolo[2,3-d]pyrimidine scaffold.
Gao LJ; Schwed JS; Weizel L; De Jonghe S; Stark H; Herdewijn P
Bioorg Med Chem Lett; 2013 Jan; 23(1):132-7. PubMed ID: 23218604
[TBL] [Abstract][Full Text] [Related]
39. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
[TBL] [Abstract][Full Text] [Related]
40. Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor.
Kiss R; Noszál B; Rácz A; Falus A; Eros D; Keseru GM
Eur J Med Chem; 2008 May; 43(5):1059-70. PubMed ID: 17900762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
